Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|December 30, 2016
Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et alDustin A DemingJournal of the National Comprehensive Cancer Network : JNCCN|January 3, 2025
Development of KRAS Inhibitors and Their Role for Metastatic Colorectal CancerDustin A DemingAnnual Review of Biomedical Engineering|March 9, 2022
Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer OrganoidsMelissa C Skala, Dustin A Deming, Jeremy D KratzBiomedical Optics Express|August 30, 2021
Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomographyDaniel A Gil, Dustin A Deming, Melissa C SkalaJournal of Gastrointestinal Oncology|July 25, 2017
Primary and acquired resistance to biologic therapies in gastrointestinal cancersSam J Lubner, Nataliya V Uboha, Dustin A DemingAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 20, 2024
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and InnovationPriyadarshini S Pathak, Gloria Chan, Dustin A Deming, et al.Biomedicines|November 27, 2025
Correction: Schmitz et al. The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. Biomedicines 2025, 13, 1319Alexa E Schmitz, Shirsa Udgata, Katherine A Johnson, et al.Biomedicines|June 26, 2025
The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid MalignanciesAlexa E Schmitz, Shirsa Udgata, Katherine A Johnson, et al.Current Colorectal Cancer Reports|May 28, 2019
Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in ReviewRebecca A DeStefanis, Jeremy D Kratz, Philip B Emmerich, et al.Current Opinion in Biomedical Engineering|December 13, 2021
Breast cancer immunotherapy: current biomarkers and the potential of in vitro assaysMelissa C Skala, Jose M Ayuso, Mark E Burkard, et al.Pageof 8